Nivalis Therapeutics, Inc. 4
4 · Nivalis Therapeutics, Inc. · Filed Jul 20, 2015
Insider Transaction Report
Form 4
LEFF JONATHAN S
Director
Transactions
- Award
Stock Option (Right to Buy)
2015-07-16+11,475→ 11,475 totalExercise: $17.49Exp: 2025-07-16→ Common Stock (11,475 underlying)
Footnotes (3)
- [F1]The exercise price is equal to the closing price per share of Common Stock as reported on the Nasdaq Global Market on the date of grant.
- [F2]The shares shall vest in 36 equal monthly installments measured commencing from June 17, 2015.
- [F3]Inapplicable.